Urinary excretion of D-glucaric acid by severely burned patients
- PMID: 761444
- DOI: 10.1002/cpt1979253340
Urinary excretion of D-glucaric acid by severely burned patients
Abstract
The 24-hr excretion of urinary D-glucaric acid (UGA) has been measured in 5 seriously burned adults and compared with 6 healthy adults. In the burn patients mean UGA was 14.4 +/- 5.4 (+/- SD) mumoles/day and 28.7 +/- 6.5 mumoles/day in controls (p less than 0.002). In a 6-year-old female, UGA was also found to be very low. In a seventh burn patient, an adult male taking 20 mg of fluphenazine until his injury, his UGA was still in the normal range (29 mumoles/day) on the day of admission but descended to 21 mumoles/day at 2 days, to 16 at 4 days, and to 13 at 6 days. Treatment with fluphenazine was then reinstituted and on the tenth day UGA was 28 mumoles/day, indicating that after thermal injury UGA can respond to drugs. Although the inference has not been proved that decreased UGA corresponds to a decreased activity of drug metabolism, there is evidence of a strong correlation between increased UGA and increased drug metabolism. A decrease of UGA in disorders that generally lower metabolic activity supports a possible correlation in severe burns. If drug metabolism activity is lowered in the seriously burned patient, drug overdose may well result from the usual clinical doses.
Similar articles
-
A new method for D-glucaric acid excretion measurement that is suitable for automated instruments.Clin Chem. 1988 Nov;34(11):2283-90. Clin Chem. 1988. PMID: 3180424
-
[D-glucaric acid excretion in kidney transplant patients as an indicator of microsomal enzyme capacity].Z Urol Nephrol. 1982 Jun;75(6):387-91. Z Urol Nephrol. 1982. PMID: 6126971 German.
-
Hepatic drug-oxidizing enzyme systems and urinary D-glucaric acid excretion in patients with congestive heart failure.Br J Clin Pharmacol. 1975 Oct;2(5):429-36. doi: 10.1111/j.1365-2125.1975.tb00552.x. Br J Clin Pharmacol. 1975. PMID: 786355 Free PMC article. Clinical Trial.
-
Urinary excretion of D-glucaric acid, an indicator of drug metabolizing enzyme activity, in patients with impaired renal function.Eur J Clin Pharmacol. 1980 Oct;18(3):255-61. doi: 10.1007/BF00563008. Eur J Clin Pharmacol. 1980. PMID: 7439245
-
Increased urinary excretion of D-glucaric acid in alcoholism.Res Commun Chem Pathol Pharmacol. 1976 Dec;15(4):735-42. Res Commun Chem Pathol Pharmacol. 1976. PMID: 1005917
Cited by
-
Aztreonam pharmacokinetics in burn patients.Antimicrob Agents Chemother. 1991 Jan;35(1):57-61. doi: 10.1128/AAC.35.1.57. Antimicrob Agents Chemother. 1991. PMID: 2014982 Free PMC article. Clinical Trial.
-
Role of interleukin-1 in the depression of liver drug metabolism by endotoxin.Infect Immun. 1986 Dec;54(3):837-40. doi: 10.1128/iai.54.3.837-840.1986. Infect Immun. 1986. PMID: 3491050 Free PMC article.
-
Clinical pharmacokinetics in patients with burns.Clin Pharmacokinet. 1995 Jul;29(1):15-28. doi: 10.2165/00003088-199529010-00003. Clin Pharmacokinet. 1995. PMID: 7586895 Review.